Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Approved for use through 08/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90881751
Filing Date:08/13/2021
To the Commissioner for Trademarks:
MARK: MEDIMMUNE (Standard Characters, see mark)
The literal element of the mark consists of MEDIMMUNE. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, MedImmune, LLC, a limited liability company legally organized under the laws of Delaware, having an address of
One MedImmune Way
Gaithersburg, Maryland 20878
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations and substances for treatment of respiratory diseases and disorders
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 09/10/1998, and first used in
commerce at least as early as 09/10/1998, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) product packaging. Specimen File1
Webpage URL: None Provided
Webpage Date of Access: None Provided
The owner's/holder's proposed attorney information: Cara M. Kearney. Cara M. Kearney of AstraZeneca Pharmaceuticals LP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no.
XXX, is located at
A2C
1800 Concord Pike
Wilmington, Delaware 19850-5437
United States
302-886-6926(phone)
3028853762(fax)
cara.kearney@astrazeneca.com
Cara M. Kearney submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /cmk/ Date: 08/13/2021
Signatory's Name: Cara M. Kearney
Signatory's Position: Attorney of records, Pennsylvania bar member
Signatory's Phone Number: 302-886-6926
Signature method: Sent to third party for signature
Payment Sale Number: 90881751
Payment Accounting Date: 08/13/2021
Serial Number: 90881751
Internet Transmission Date: Fri Aug 13 14:24:30 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XX.XXX-2021081314243046
4688-90881751-781926c6fb5497b194f9b04d37
49fff12eadfb7cb928d22ff5710ff5ff563-DA-2
4300493-20210813124832666322